Trade Benitec Biopharma Inc. - BNTC CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.1478
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021596 %(-$4.32)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.02160%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000626 %(-$0.13)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.00063%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021596 %
  (-$4.32)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000626 %
  (-$0.13)

Key Stats

• Prev. Close: 12.2861
• Open: 12.2961
• 1-Year Change: -11.33%
• Day's Range: 12.2061 - 12.6961

Trade Benitec Biopharma Inc. - BNTC

What is Benitec Biopharma Inc. (BNTC)?

Benitec Biopharma Inc. is a biotechnology company specializing in the development of gene-based therapies. The company focuses on utilizing gene silencing technologies, including RNA interference and DNA-directed RNA interference, to address chronic and life-threatening diseases. Its research and development efforts target conditions such as hepatitis B, ocular diseases, and other genetic disorders. Benitec Biopharma collaborates with academic institutions and industry partners to advance its therapeutic candidates through preclinical and clinical stages. The company aims to harness novel molecular approaches to modulate gene expression, offering potential treatment options where traditional therapies may be limited. Headquartered in Australia, Benitec Biopharma operates within the global biopharmaceutical sector, contributing to the evolving landscape of genetic medicine. Its scientific platform is built on proprietary technologies designed to improve the specificity and durability of gene silencing effects. The company’s activities encompass research, development, and potential commercialization of innovative therapies based on nucleic acid technologies.

Benitec Biopharma Inc. Stock Price Today: Live Overview

The price today is shaped by active trading, with Benitec Biopharma Inc. holding at $12.7739. The price has ranged from $12.2061 to $12.6161 during today’s session, with a daily change of +2.5232%.

FAQ: Benitec Biopharma Inc. (BNTC)

What is the current price of BNTC stock?

Benitec Biopharma Inc. closed at $12.7739 today.

Does BNTC pay dividends?

The company pays dividends via cash distributions (if applicable).

Does BNTC have a formal corporate presence or regional headquarters in the UAE?

Benitec Biopharma Inc. operates via partners and distributors in the UAE without an official regional office or subsidiary.

What is BNTC best known for?

Benitec Biopharma Inc. is most famous for its work in gene silencing therapeutics.

What assets are typically shown together with BNTC?

Commonly shown alongside BNTC: Molson Coors, Marks & Spencer Group PLC, Cleveland-Cliffs